Asset Details
Do you wish to reserve the book?
Probiotics Containing Collagen Peptides for Weight Loss and Improvement of Brain Disorders Caused by Obesity in a Mouse Model
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Probiotics Containing Collagen Peptides for Weight Loss and Improvement of Brain Disorders Caused by Obesity in a Mouse Model
Do you wish to request the book?
Probiotics Containing Collagen Peptides for Weight Loss and Improvement of Brain Disorders Caused by Obesity in a Mouse Model
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Probiotics Containing Collagen Peptides for Weight Loss and Improvement of Brain Disorders Caused by Obesity in a Mouse Model
2025
Overview
Collagen peptide was identified as a prebiotic that can provide nitrogen and carbon sources for probiotics to achieve antiobesity, anti‐inflammatory, antioxidant, and immunoregulatory effects by improving the gut microbiota. Also, obesity is a high‐risk factor for psychological and cognitive diseases. This study used a commercialized collagen peptide probiotic (CPP) containing 12 strains of proprietary probiotics with collagen peptides from fish skin to evaluate weight control, fat formation, blood sugar control, and anxiety behavior effects in mice fed a high‐fat diet (HFD) or high‐carbohydrate diet (HCD) and compared the effects by the clinical weight loss drug orlistat (ORL). The results showed that CPP was more effective than ORL in slowing the weight gain in HCD‐ or HFD‐fed male mice. However, the effects of CPP and ORL in female mice were slightly different. Regardless of gender, CPP significantly reduced fat formation and improved glucose tolerance caused by HCD or HFD. Blood biochemical analysis also revealed that CPP could restore HCD‐ and HFD‐induced liver and kidney dysfunction in male but not in female mice. The total cholesterol, triglycerides, and leptin concentrations in the blood decreased with CPP compared to the ORL intervention. In addition, CPP alleviated HCD‐ and HFD‐induced anxiety in mice and improved their gut microbiota. This study confirmed that this CPP product has more antiobesity effects and can ameliorate other related damage caused by HCD and HFD than the clinical weight loss drug ORL. Thus, CPP has a strong potential to be widely used for human health promotion and disease prevention.
